NIKOLAS RADEMAKER: Open Payments
NPI 1144996661 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,987 in 91 payments from 37 companies in 2025. Trend: 2023 $113 · 2024 $751 · 2025 $1,987
Food & beverage: $1,987
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $220 |
| AstraZeneca Pharmaceuticals LP | 9 | $178 |
| GENZYME CORPORATION | 1 | $150 |
| ABBVIE INC. | 6 | $138 |
| PFIZER INC. | 6 | $127 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Janssen Biotech, Inc. | 3 | $68 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Incyte Corporation | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $54 |
Products named: SARCLISA, SCEMBLIX, Fabhalta, REXULTI, AIRSUPRA, Auvelity, Ohtuvayre, AUSTEDO XR.
Industry payments across WA — which companies pay providers there.
